AG百家乐大转轮-AG百家乐导航_怎么看百家乐走势_全讯网官网 (中国)·官方网站

Research News

Bronchial Thermoplasty was carried out successfully in the respiratory department of The Sixth Affiliated Hospital

Source: The Sixth Affiliated Hospital
Written by: Jian Wenyang, Wang Jun
Edited by: Wang Dongmei

Professor Gerard Cox from McMaster University in Canada visited the respiratory department of The Sixth Affiliated Hospital of SYSU recently. Professor Chen Zhengxian, the Chief Physician of the department, and his team gave reception to Professor Gerard Cox. They discussed an innovative technology in treatment of severe asthma, Bronchial Thermoplasty (BT), and examined patients who were candidated for BT. Professor Cox also gave a lecture about the operational essentials, safety and clinical outcome of Bronchial Thermoplasty. The event laid a foundation for the promotion of Bronchial Thermoplasty in China.

 
Professor Gerard Cox (first from left) from McMaster University discussing Bronchial Thermoplasty with the team
led by Professor Chen Zhengxian (first from right) from the respiratory department of The Sixth Affiliated Hospital
 
Professor Gerard Cox, who is famous for the treatment of asthma and Bronchial Thermoplasty in Canada, offered some practical experience about screening patients, operating process and skills, and patient management of Bronchial Thermoplasty. This was really good news for patients with severe asthma.

According to Professor Chen Zhengxian, Bronchial Thermoplasty is an effective treatment for severe, uncontrolled asthma patients who were poor responding to standard drug treatment (inhaled corticosteroids and long-acting b2-agonists). This operation delivers therapeutic radiofrequency energy provided by the Alair? System to the airway wall, via a catheter inserted into the bronchi through a flexible bronchoscope, thus reducing the amount of smooth muscle cell in the airway wall and reducing the ability of the smooth muscle to bronchoconstrict. This treatment could reduce asthma symptoms and exacerbations, and improved quality of life.

The treatment has been shown to be uncomplicated, safe and effective over 10 years abroad. It was approved by the US Food and Drug Administration (FDA) and Passed Premarket Approval (PMA) process. Patients with severe persistent asthma, 18 years and older, who experience asthma symptoms despite taking high dose Corticosteroids (ICS) and Long-acting β-agonists (LABA), and can tolerant Bronchial endoscopy are indicated to Bronchial Thermoplasty. Even patients with severe airflow obstruction could be improved by this treatment.

Professor Chen Zhenxian is a well known Interventional Pulmonology specialist and his team is developing this promising technology. More and more patients will benefit from this therapy.

百家乐天下| 百家乐官网家乐娱乐城| 百家乐官网赌坊| 百家乐官网道具扫描| 百家乐官网解析| 百家乐官网庄家必赢诀窍| 喀喇沁旗| 大发888二十一点| 百家乐开户优惠多的平台是哪家| 百家乐输了好多钱| 线上百家乐平玩法| 太阳城百家乐公司| 大发888充值| 威尼斯人娱乐城线上博彩| 大发888游戏平台 df888ylcxz46| 大发888信用好不好| 棋牌捕鱼| 168棋牌游戏| 百家乐官网缆的打法| 庐江县| 百家乐官网游戏合法吗| 澳门百家乐官网赌场网址| 百家乐注册下注平台| 致胜百家乐下载| 百家乐2号死机| 百家乐合| 大发888娱乐城取款| 百家乐官网冯耕耘打法| 网络百家乐官网怎样出千| 百家乐官网赚钱方| 百家乐娱乐城代理| 百家乐百战百胜| 大发888手机版下载官方网站| 十堰市| 百家乐官网园sun811.com| 百家乐官网骰盅规则| 威尼斯人娱乐城可信吗| 稳赢的百家乐官网投注方法| 海立方百家乐官网海立方| 百家乐官网九| 大连百家乐食品|